+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Head and Neck Cancer Diagnostic Market Analysis & Forecast 2024-2034: Market By Diagnostic Method; By End-user; and By Region

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5890319
The global head and neck cancer diagnostic market size was estimated to be USD 5.48 billion in 2023 and is expected to reach at USD 18.99 billion by 2034 with a CAGR of 11.96% during the forecast period 2024-2034. Increasing prevalence of head & neck cancer, growing geriatric population, surge in number of diagnostic procedures for head & neck cancer, availability of several diagnostic techniques for head & neck cancer, rising initiatives taken by research institutes to increase awareness regarding head & neck cancer, increasing technological advancements, growing demand for early diagnosis of the disease, and surge in approval of AI-based platforms are some of the key factors boosting the market growth.

Surge in approval of AI-based platforms is predicted to boost the market growth during the forecast period. Medical examinations like endoscopy, head MRI, CT scans of the sinuses and head, panoramic dental x-rays, dental cone beam CT scans, PET/CT scans, and chest imaging are employed to verify cancer diagnoses and determine the malignancy's spread. The expectation is that regulatory authorities will grant approvals for the growing adoption of these diagnostic techniques. For instance, in October 2022, The FDA has granted approval to Philips for its AI-driven MRI platform designed for the diagnosis of head and neck cancers.

By diagnostic method, diagnostic imaging equipment was the highest revenue-grossing segment in the global head and neck cancer diagnostic market in 2023 owing to growing demand for early diagnosis, rising new product launches, and surge in approvals by regulatory bodies. Additionally, endoscopy screening equipment is predicted to grow at fastest CAGR during the forecast period owing to the rising advancements in endoscopic technologies, growing launch of technologically advanced products, increasing research & development activities, and surge in initiatives by major market players. For instance, in July 2022, The establishment of the International Center for Recurrent Head & Neck Cancer (IReC) is aimed at expediting research efforts and enhancing results for patients. IReC's objectives also include establishing global benchmarks for effective treatment, palliative care, and supportive services for recurrent head and neck cancer, ultimately improving patient outcomes not only in the UK but also on a global scale.

By End-user, Hospitals was the highest revenue-grossing segment in the global head and neck cancer diagnostic market in 2023 owing to rising prevalence of head & neck cancer, increasing adoption of advanced technologies, and growing launch of advanced products. For instance, in October 2022, Global health technology leader, Royal Philips, has introduced two innovative developments in MR-only workflows aimed at enhancing imaging and simulation for radiotherapy of head and neck cancer. Additionally, Diagnostic centres is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for advanced early diagnostic tools, rising technological advancements, and increasing regulatory approvals of novel products.

North America region is anticipated for the highest revenue share during the forecast period owing to the growing adoption of cancer diagnostics, increasing incidences of cancer, rising awareness initiatives regarding the head & neck cancer, surge in new product launches by leading market players. For instance, in August 2022, Viome Life Science has introduced CancerDetect, an in-home testing solution designed to detect oral and throat cancer. This test provides exceptional precision in early cancer detection and prevention, being the sole oral and throat cancer test to achieve a specificity of 95% and a sensitivity of 90%. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing geriatric population, growing use of immunotherapeutic drugs, surge in approvals by regulatory bodies, and rising initiatives by leading market players. For instance, in July 2023, Biocon Foundation has launched the second edition of the India-specific Consensus Guidelines for Head and Neck Cancer (HNC) management, which were developed by the Oral Cancer Task Force (OCTF). This release coincides with World Head and Neck Cancer Day.

Segmentation: Head and Neck Cancer Diagnostic Market Report 2022 - 2033

Head and Neck Cancer Diagnostic Market Analysis & Forecast by Diagnostic Method 2023 - 2034 (Revenue USD Bn)

  • Endoscopy Screening Equipment
  • Dental Diagnostic Methods
  • Diagnostic Imaging Equipment
  • Bioscopy Screening Tests
  • Other

Head and Neck Cancer Diagnostic Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)

  • Diagnostic Centres
  • Hospitals
  • Others

Head and Neck Cancer Diagnostic Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Head and Neck Cancer Diagnostic Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Head and Neck Cancer Diagnostic Market: Diagnostic Method Estimates & Trend Analysis
7.1. Diagnostic Method Segment Opportunity Analysis
7.2. Endoscopy Screening Equipment
7.2.1. Endoscopy Screening Equipment Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Dental Diagnostic Methods
7.3.1. Dental Diagnostic Methods Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Diagnostic Imaging Equipment
7.4.1. Diagnostic Imaging Equipment Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Bioscopy Screening Tests
7.5.1. Bioscopy Screening Tests Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Other
7.6.1. Other Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Head and Neck Cancer Diagnostic Market: End-user Estimates & Trend Analysis
8.1. End-user Segment Opportunity Analysis
8.2. Diagnostic Centres
8.2.1. Diagnostic Centres Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Hospitals
8.3.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Others
8.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Regional Market Analysis
9.1. Regional Market Opportunity Analysis
10. North America Head and Neck Cancer Diagnostic Market
10.1. North America Head and Neck Cancer Diagnostic Market
10.1.1. North America Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.1.2. North America Head and Neck Cancer Diagnostic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
10.1.3. North America Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
10.1.4. North America Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
10.2. U.S. Global Head and Neck Cancer Diagnostic Market
10.2.1. U.S. Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.2.2. U.S. Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
10.2.3. U.S. Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
10.3. Canada Global Head and Neck Cancer Diagnostic Market
10.3.1. Canada Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
10.3.2. Canada Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
10.3.3. Canada Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11. Europe Global Head and Neck Cancer Diagnostic Market
11.1. Europe Global Head and Neck Cancer Diagnostic Market
11.1.1. Europe Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. Europe Head and Neck Cancer Diagnostic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. Europe Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
11.1.4. Europe Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.2. Germany Global Head and Neck Cancer Diagnostic Market
11.2.1. Germany Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. Germany Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
11.2.3. Germany Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.3. UK Global Head and Neck Cancer Diagnostic Market
11.3.1. UK Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. UK Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
11.3.3. UK Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.4. France Global Head and Neck Cancer Diagnostic Market
11.4.1. France Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.4.2. France Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
11.4.3. France Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.5. Spain Global Head and Neck Cancer Diagnostic Market
11.5.1. Spain Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.5.2. Spain Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
11.5.3. Spain Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.6. Italy Global Head and Neck Cancer Diagnostic Market
11.6.1. Italy Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.6.2. Italy Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
11.6.3. Italy Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
11.7. Rest of Europe Global Head and Neck Cancer Diagnostic Market
11.7.1. Rest of Europe Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.7.2. Rest of Europe Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
11.7.3. Rest of Europe Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12. Asia Pacific Global Head and Neck Cancer Diagnostic Market
12.1. Asia Pacific Global Head and Neck Cancer Diagnostic Market
12.1.1. Asia Pacific Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Asia Pacific Head and Neck Cancer Diagnostic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Asia Pacific Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
12.1.4. Asia Pacific Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.2. Japan Global Head and Neck Cancer Diagnostic Market
12.2.1. Japan Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Japan Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
12.2.3. Japan Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.3. China Global Head and Neck Cancer Diagnostic Market
12.3.1. China Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. China Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
12.3.3. China Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.4. India Global Head and Neck Cancer Diagnostic Market
12.4.1. India Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. India Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
12.4.3. India Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.5. South Korea Global Head and Neck Cancer Diagnostic Market
12.5.1. South Korea Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. South Korea Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
12.5.3. South Korea Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.6. Australia Global Head and Neck Cancer Diagnostic Market
12.6.1. Australia Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Australia Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
12.6.3. Australia Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
12.7. Rest of Asia Pacific Global Head and Neck Cancer Diagnostic Market
12.7.1. Rest of Asia Pacific Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Asia Pacific Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Asia Pacific Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13. Latin America Global Head and Neck Cancer Diagnostic Market
13.1. Latin America Global Head and Neck Cancer Diagnostic Market
13.1.1. Latin America Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Latin America Head and Neck Cancer Diagnostic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Latin America Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
13.1.4. Latin America Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.2. Brazil Global Head and Neck Cancer Diagnostic Market
13.2.1. Brazil Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Brazil Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
13.2.3. Brazil Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.3. Mexico Global Head and Neck Cancer Diagnostic Market
13.3.1. Mexico Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. Mexico Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
13.3.3. Mexico Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.4. Argentina Global Head and Neck Cancer Diagnostic Market
13.4.1. Argentina Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. Argentina Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
13.4.3. Argentina Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
13.5. Rest of Latin America Global Head and Neck Cancer Diagnostic Market
13.5.1. Rest of Latin America Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. Rest of Latin America Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
13.5.3. Rest of Latin America Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14. MEA Global Head and Neck Cancer Diagnostic Market
14.1. MEA Global Head and Neck Cancer Diagnostic Market
14.1.1. MEA Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. MEA Head and Neck Cancer Diagnostic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. MEA Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
14.1.4. MEA Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.2. GCC Global Head and Neck Cancer Diagnostic Market
14.2.1. GCC Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. GCC Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
14.2.3. GCC Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.3. South Africa Global Head and Neck Cancer Diagnostic Market
14.3.1. South Africa Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. South Africa Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
14.3.3. South Africa Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
14.4. Rest of MEA Global Head and Neck Cancer Diagnostic Market
14.4.1. Rest of MEA Head and Neck Cancer Diagnostic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Rest of MEA Head and Neck Cancer Diagnostic Market Size and Forecast, By Diagnostic Method, 2023-2034 (Revenue USD Bn)
14.4.3. Rest of MEA Head and Neck Cancer Diagnostic Market Size and Forecast, By End-user, 2023-2034 (Revenue USD Bn)
15. Competitor Analysis
15.1. Company Market Share Analysis, 2023
15.2. Major Recent Developments
16. Company Profiles
16.1. Fujifilm
16.2. GE Healthcare
16.3. Canon Medical system Corporation
16.4. Philips Healthcare
16.5. Identafi
16.6. Carestream Healthcare
16.7. Addent Inc
16.8. Neusoft Medical
16.9. Siemens Healthineers
16.10. Shimadzu Corporation
16.11. Planet DDS (Apteryx Imaging Inc)
16.12. Other Prominent Players
17. Conclusion18. Recommendations

Companies Mentioned

  • Fujifilm
  • GE Healthcare
  • Canon Medical system Corporation
  • Philips Healthcare
  • Identafi
  • Carestream Healthcare
  • Addent Inc
  • Neusoft Medical
  • Siemens Healthineers
  • Shimadzu Corporation
  • Planet DDS (Apteryx Imaging Inc)

Table Information